View ValuationChengzhi 将来の成長Future 基準チェック /06現在、 Chengzhiの成長と収益を予測するのに十分なアナリストの調査がありません。主要情報n/a収益成長率n/aEPS成長率Chemicals 収益成長28.8%収益成長率n/a将来の株主資本利益率n/aアナリストカバレッジNone最終更新日n/a今後の成長に関する最新情報更新なしすべての更新を表示Recent updatesBoard Change • Jul 08High number of new and inexperienced directorsThere are 9 new directors who have joined the board in the last 3 years. The company's board is composed of: 9 new directors. 2 experienced directors. No highly experienced directors. Non-Employee Supervisor Shan Liu is the most experienced director on the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.お知らせ • Jun 30Chengzhi Co., Ltd. to Report First Half, 2026 Results on Aug 13, 2026Chengzhi Co., Ltd. announced that they will report first half, 2026 results on Aug 13, 2026お知らせ • Jun 09Chengzhi Co., Ltd., Annual General Meeting, Jun 29, 2026Chengzhi Co., Ltd., Annual General Meeting, Jun 29, 2026, at 14:00 China Standard Time. Location: 17F, Tower B, Innovation Building, Tsinghua Science and Technology Park, Beijing Chinaお知らせ • Mar 31Chengzhi Co., Ltd. to Report Q1, 2026 Results on Apr 15, 2026Chengzhi Co., Ltd. announced that they will report Q1, 2026 results on Apr 15, 2026お知らせ • Dec 31Chengzhi Co., Ltd. to Report Fiscal Year 2025 Results on Apr 15, 2026Chengzhi Co., Ltd. announced that they will report fiscal year 2025 results on Apr 15, 2026お知らせ • Sep 30Chengzhi Co., Ltd. to Report Q3, 2025 Results on Oct 25, 2025Chengzhi Co., Ltd. announced that they will report Q3, 2025 results on Oct 25, 2025お知らせ • Jul 02Chengzhi Co., Ltd. to Report First Half, 2025 Results on Aug 08, 2025Chengzhi Co., Ltd. announced that they will report first half, 2025 results on Aug 08, 2025お知らせ • Apr 18Chengzhi Co., Ltd. Approves Cash Dividend for 2024Chengzhi Co., Ltd. announced at its annual general meeting of 2024 held on 16 April 2025, approved the cash dividend of CNY 0.50000000 per 10 shares (tax included).お知らせ • Mar 31Chengzhi Co., Ltd. to Report Q1, 2025 Results on Apr 24, 2025Chengzhi Co., Ltd. announced that they will report Q1, 2025 results on Apr 24, 2025お知らせ • Mar 28Chengzhi Co., Ltd. Proposes Final Cash Dividend for 2024Chengzhi Co., Ltd. announced on 27 March 2025 the profit distribution proposal for 2024 as follows: final cash dividend of CNY 0.50000000 per 10 shares (tax included).お知らせ • Mar 27Chengzhi Co., Ltd., Annual General Meeting, Apr 16, 2025Chengzhi Co., Ltd., Annual General Meeting, Apr 16, 2025, at 14:00 China Standard Time. Location: 17F, Tower B, Innovation Building, Tsinghua Science and Technology Park, Beijing Chinaお知らせ • Dec 31Chengzhi Co., Ltd. to Report Fiscal Year 2024 Results on Mar 27, 2025Chengzhi Co., Ltd. announced that they will report fiscal year 2024 results on Mar 27, 2025Reported Earnings • Oct 25Third quarter 2024 earnings released: EPS: CN¥0.026 (vs CN¥0.14 in 3Q 2023)Third quarter 2024 results: EPS: CN¥0.026 (down from CN¥0.14 in 3Q 2023). Revenue: CN¥2.58b (down 26% from 3Q 2023). Net income: CN¥31.3m (down 81% from 3Q 2023). Profit margin: 1.2% (down from 4.8% in 3Q 2023). Revenue is forecast to grow 20% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 47 percentage points per year, which is a significant difference in performance.お知らせ • Sep 30Chengzhi Co., Ltd. to Report Q3, 2024 Results on Oct 25, 2024Chengzhi Co., Ltd. announced that they will report Q3, 2024 results on Oct 25, 2024Valuation Update With 7 Day Price Move • Sep 27Investor sentiment improves as stock rises 18%After last week's 18% share price gain to CN¥7.53, the stock trades at a forward P/E ratio of 29x. Average forward P/E is 16x in the Chemicals industry in China. Total loss to shareholders of 53% over the past three years.Reported Earnings • Jul 26Second quarter 2024 earnings released: EPS: CN¥0.027 (vs CN¥0.017 in 2Q 2023)Second quarter 2024 results: EPS: CN¥0.027 (up from CN¥0.017 in 2Q 2023). Revenue: CN¥2.94b (down 7.7% from 2Q 2023). Net income: CN¥33.1m (up 59% from 2Q 2023). Profit margin: 1.1% (up from 0.7% in 2Q 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 53 percentage points per year, which is a significant difference in performance.お知らせ • Jun 29Chengzhi Co., Ltd. to Report First Half, 2024 Results on Jul 26, 2024Chengzhi Co., Ltd. announced that they will report first half, 2024 results on Jul 26, 2024Declared Dividend • May 25Dividend reduced to CN¥0.05Dividend of CN¥0.05 is 55% lower than last year. Ex-date: 29th May 2024 Payment date: 29th May 2024 Dividend yield will be 0.6%, which is lower than the industry average of 2.6%.お知らせ • May 25Chengzhi Co., Ltd. Announces Final Cash Dividend on A Shares for the Year 2023, Payable on 29 May 2024Chengzhi Co., Ltd. announced final cash dividend/10 shares (tax included) of CNY 0.50000000 on A shares for the year 2023. Record date: 28 May 2024. Ex-date: 29 May 2024. Payment date: 29 May 2024.Valuation Update With 7 Day Price Move • May 10Investor sentiment improves as stock rises 16%After last week's 16% share price gain to CN¥8.95, the stock trades at a trailing P/E ratio of 28x. Average trailing P/E is 35x in the Chemicals industry in China. Total loss to shareholders of 35% over the past three years.Reported Earnings • Apr 17First quarter 2024 earnings released: EPS: CN¥0.13 (vs CN¥0.047 loss in 1Q 2023)First quarter 2024 results: EPS: CN¥0.13 (up from CN¥0.047 loss in 1Q 2023). Revenue: CN¥2.72b (down 19% from 1Q 2023). Net income: CN¥154.1m (up CN¥211.0m from 1Q 2023). Profit margin: 5.7% (up from net loss in 1Q 2023). Revenue is forecast to grow 17% p.a. on average during the next 2 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 60 percentage points per year, which is a significant difference in performance.お知らせ • Apr 05Chengzhi Co., Ltd. Approves Cash Dividend for 2023Chengzhi Co., Ltd. at its Annual General Meeting of 2023 held on 02 April 2024, the shareholders approved: cash dividend/10 shares (tax included): CNY 0.50000000 for the year 2023.お知らせ • Mar 30Chengzhi Co., Ltd. to Report Q1, 2024 Results on Apr 17, 2024Chengzhi Co., Ltd. announced that they will report Q1, 2024 results on Apr 17, 2024お知らせ • Mar 14Chengzhi Co., Ltd., Annual General Meeting, Apr 02, 2024Chengzhi Co., Ltd., Annual General Meeting, Apr 02, 2024, at 14:00 China Standard Time. Location: 17F, Tower B, Innovation Building, TusPark, Beijing China Agenda: To consider 2023 work report of the board of directors; to 2023 work report of the supervisory committee; to 2023 annual report and its summary; to 2023 annual accounts report; to 2023 profit distribution plan; to 2023 assets write-off and provision for assets impairment; to 2024 application for comprehensive credit line to banks; to 2024 provision of guarantee for controlled subsidiaries; and to consider other matters.Reported Earnings • Mar 13Full year 2023 earnings released: EPS: CN¥0.15 (vs CN¥0.044 in FY 2022)Full year 2023 results: EPS: CN¥0.15 (up from CN¥0.044 in FY 2022). Revenue: CN¥12.4b (up 6.0% from FY 2022). Net income: CN¥177.4m (up 236% from FY 2022). Profit margin: 1.4% (up from 0.5% in FY 2022). Revenue is forecast to grow 13% p.a. on average during the next 2 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 55 percentage points per year, which is a significant difference in performance.Valuation Update With 7 Day Price Move • Feb 02Investor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to CN¥6.72, the stock trades at a forward P/E ratio of 17x. Average forward P/E is 13x in the Chemicals industry in China. Total loss to shareholders of 38% over the past three years.お知らせ • Dec 30Chengzhi Co., Ltd. to Report Fiscal Year 2023 Results on Feb 29, 2024Chengzhi Co., Ltd. announced that they will report fiscal year 2023 results on Feb 29, 2024New Risk • Dec 22New major risk - Revenue and earnings growthEarnings have declined by 22% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 22% per year over the past 5 years. Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Large one-off items impacting financial results.お知らせ • Dec 13+ 1 more updateChengzhi Co., Ltd.(SZSE:000990) dropped from Shenzhen Stock Exchange Component IndexChengzhi Shareholding Co., Ltd. has been removed from Shenzhen Stock Exchange Component Index .Reported Earnings • Oct 27Third quarter 2023 earnings released: EPS: CN¥0.14 (vs CN¥0.098 loss in 3Q 2022)Third quarter 2023 results: EPS: CN¥0.14 (up from CN¥0.098 loss in 3Q 2022). Revenue: CN¥3.47b (up 22% from 3Q 2022). Net income: CN¥166.9m (up CN¥285.3m from 3Q 2022). Profit margin: 4.8% (up from net loss in 3Q 2022). Revenue is forecast to grow 12% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 57% per year but the company’s share price has only fallen by 16% per year, which means it has not declined as severely as earnings.お知らせ • Sep 30Chengzhi Co., Ltd. to Report Q3, 2023 Results on Oct 27, 2023Chengzhi Co., Ltd. announced that they will report Q3, 2023 results on Oct 27, 2023お知らせ • Jul 01Chengzhi Co., Ltd. to Report First Half, 2023 Results on Aug 12, 2023Chengzhi Co., Ltd. announced that they will report first half, 2023 results on Aug 12, 2023お知らせ • Jun 06Chengzhi Co., Ltd. Announces 2022 Final Profit Distribution Plan to Be Implemented (A Shares), Payable on 09 June 2023Chengzhi Co., Ltd. announced 2022 final profit distribution plan to be implemented (A shares) of Cash dividend/10 shares (tax included): CNY 1.10000000. Record date: 08 June 2023; Ex-date: 09 June 2023; Payment date: 09 June 2023.Reported Earnings • Mar 26Full year 2022 earnings released: EPS: CN¥0.044 (vs CN¥0.83 in FY 2021)Full year 2022 results: EPS: CN¥0.044 (down from CN¥0.83 in FY 2021). Revenue: CN¥11.7b (down 3.8% from FY 2021). Net income: CN¥52.9m (down 95% from FY 2021). Profit margin: 0.5% (down from 8.3% in FY 2021). Over the last 3 years on average, earnings per share has increased by 6% per year but the company’s share price has fallen by 12% per year, which means it is significantly lagging earnings.Board Change • Nov 16High number of new and inexperienced directorsThere are 8 new directors who have joined the board in the last 3 years. The company's board is composed of: 8 new directors. 2 experienced directors. No highly experienced directors. Independent Director Yaxiong Guo is the most experienced director on the board, commencing their role in 2017. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.Reported Earnings • Oct 29Third quarter 2022 earnings released: CN¥0.098 loss per share (vs CN¥0.30 profit in 3Q 2021)Third quarter 2022 results: CN¥0.098 loss per share (down from CN¥0.30 profit in 3Q 2021). Revenue: CN¥2.84b (down 11% from 3Q 2021). Net loss: CN¥118.5m (down 132% from profit in 3Q 2021). Over the last 3 years on average, earnings per share has increased by 18% per year but the company’s share price has fallen by 14% per year, which means it is significantly lagging earnings.Board Change • Oct 09High number of new and inexperienced directorsThere are 7 new directors who have joined the board in the last 3 years. The company's board is composed of: 7 new directors. 5 experienced directors. No highly experienced directors. Independent Director Yaxiong Guo is the most experienced director on the board, commencing their role in 2017. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.Reported Earnings • Jul 25First half 2022 earnings released: EPS: CN¥0.12 (vs CN¥0.61 in 1H 2021)First half 2022 results: EPS: CN¥0.12 (down from CN¥0.61 in 1H 2021). Revenue: CN¥6.48b (up 1.3% from 1H 2021). Net income: CN¥149.9m (down 80% from 1H 2021). Profit margin: 2.3% (down from 12% in 1H 2021). Over the last 3 years on average, earnings per share has increased by 30% per year but the company’s share price has fallen by 12% per year, which means it is significantly lagging earnings.Buying Opportunity • Jul 23Now 21% undervalued after recent price dropOver the last 90 days, the stock is down 4.9%. The fair value is estimated to be CN¥12.87, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 29% over the last 3 years. Earnings per share has grown by 31%.Buying Opportunity • Jul 06Now 20% undervalued after recent price dropOver the last 90 days, the stock is down 14%. The fair value is estimated to be CN¥13.39, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 29% over the last 3 years. Earnings per share has grown by 31%. Revenue is forecast to grow by 29% in 2 years. Earnings is forecast to decline by 12% in the next 2 years.Buying Opportunity • Jun 10Now 20% undervalued after recent price dropOver the last 90 days, the stock is down 16%. The fair value is estimated to be CN¥13.05, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 29% over the last 3 years. Earnings per share has grown by 31%. Revenue is forecast to grow by 29% in 2 years. Earnings is forecast to decline by 12% in the next 2 years.Reported Earnings • Apr 27First quarter 2022 earnings released: EPS: CN¥0.12 (vs CN¥0.27 in 1Q 2021)First quarter 2022 results: EPS: CN¥0.12 (down from CN¥0.27 in 1Q 2021). Revenue: CN¥3.36b (up 12% from 1Q 2021). Net income: CN¥146.4m (down 55% from 1Q 2021). Profit margin: 4.4% (down from 11% in 1Q 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 31% per year but the company’s share price has fallen by 26% per year, which means it is significantly lagging earnings.Reported Earnings • Oct 20Third quarter 2021 earnings released: EPS CN¥0.30 (vs CN¥0.20 in 3Q 2020)The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: CN¥3.17b (up 17% from 3Q 2020). Net income: CN¥365.7m (up 49% from 3Q 2020). Profit margin: 12% (up from 9.1% in 3Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 14% per year but the company’s share price has only increased by 7% per year, which means it is significantly lagging earnings growth.Valuation Update With 7 Day Price Move • Aug 04Investor sentiment improved over the past weekAfter last week's 24% share price gain to CN¥17.47, the stock trades at a forward P/E ratio of 14x. Average forward P/E is 19x in the Chemicals industry in China. Total returns to shareholders of 29% over the past three years.Reported Earnings • Jul 27Second quarter 2021 earnings released: EPS CN¥0.34 (vs CN¥0.042 loss in 2Q 2020)The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: CN¥3.41b (up 73% from 2Q 2020). Net income: CN¥416.4m (up CN¥467.2m from 2Q 2020). Profit margin: 12% (up from net loss in 2Q 2020). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 6% per year but the company’s share price has increased by 2% per year, which means it is well ahead of earnings.Reported Earnings • Apr 16First quarter 2021 earnings released: EPS CN¥0.27 (vs CN¥0.13 loss in 1Q 2020)The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: CN¥2.99b (up 49% from 1Q 2020). Net income: CN¥322.3m (up CN¥477.8m from 1Q 2020). Profit margin: 11% (up from net loss in 1Q 2020). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 30% per year but the company’s share price has only fallen by 4% per year, which means it has not declined as severely as earnings.Analyst Estimate Surprise Post Earnings • Mar 05Revenue beats expectationsRevenue exceeded analyst estimates by 25%. Over the next year, revenue is expected to shrink by 14% compared to a 51% growth forecast for the Chemicals industry in China.Reported Earnings • Mar 05Full year 2020 earnings released: EPS CN¥0.29 (vs CN¥0.36 in FY 2019)The company reported a mediocre full year result with weaker earnings and profit margins, although revenues improved. Full year 2020 results: Revenue: CN¥9.73b (up 41% from FY 2019). Net income: CN¥355.1m (down 20% from FY 2019). Profit margin: 3.6% (down from 6.4% in FY 2019). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 44% per year but the company’s share price has only fallen by 5% per year, which means it has not declined as severely as earnings.Is New 90 Day High Low • Mar 05New 90-day high: CN¥14.38The company is up 1.0% from its price of CN¥14.27 on 04 December 2020. The Chinese market is also up 1.0% over the last 90 days, indicating the company’s price trend is similar to the market over that time. However, it underperformed the Chemicals industry, which is up 11% over the same period.Is New 90 Day High Low • Jan 27New 90-day low: CN¥11.00The company is down 15% from its price of CN¥12.95 on 30 October 2020. The Chinese market is up 9.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 21% over the same period.Is New 90 Day High Low • Jan 11New 90-day low: CN¥11.21The company is down 15% from its price of CN¥13.24 on 14 October 2020. The Chinese market is up 5.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 12% over the same period.Is New 90 Day High Low • Dec 25New 90-day low: CN¥12.78The company is down 1.0% from its price of CN¥12.94 on 25 September 2020. The Chinese market is up 5.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 10.0% over the same period. このセクションでは通常、投資家が会社の利益創出能力を理解する一助となるよう、プロのアナリストのコンセンサス予想に基づく収益と利益の成長予測を提示する。しかし、Chengzhi は十分な過去のデータを提供しておらず、アナリストの予測もないため、過去のデータを外挿したり、アナリストの予測を使用しても、その将来の収益を確実に算出することはできません。 シンプリー・ウォール・ストリートがカバーする企業の97%は過去の財務データを持っているため、これはかなり稀な状況です。 業績と収益の成長予測XSEC:000990 - アナリストの将来予測と過去の財務データ ( )CNY Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数3/31/202610,86671141939N/A12/31/202511,028-782511,078N/A9/30/202511,5331164321,150N/A6/30/202511,386633451,103N/A3/31/202511,343160321,219N/A12/31/202411,0662311791,379N/A9/30/202410,6382651371,634N/A6/30/202411,5274014741,956N/A3/31/202411,7733881,1952,201N/A12/31/202312,4171774891,388N/A9/30/202312,4151505811,133N/A6/30/202311,785-135526918N/A3/31/202311,723-1527221,069N/A1/1/202311,717519501,356N/A9/30/202211,927-656581,092N/A6/30/202212,2654201,1441,562N/A3/31/202212,5558331,1371,561N/A1/1/202212,1841,0081,2771,694N/A9/30/202112,6261,4212,0332,344N/A6/30/202112,1541,3001,8092,121N/A3/31/202110,7108331,1331,487N/A12/31/20209,7323559631,264N/A9/30/20209,3001396741,089N/A6/30/20208,179643741,002N/A3/31/20207,59619999922N/A12/31/20196,912443N/A1,021N/A9/30/20195,801541N/A990N/A6/30/20195,804694N/A922N/A3/31/20195,826820N/A1,279N/A1/1/20195,868849N/A1,316N/A9/30/20185,857790N/A1,486N/A6/30/20185,661739N/A1,570N/A3/31/20185,680722N/A1,372N/A12/31/20175,695809N/A1,602N/A9/30/20175,010804N/A1,270N/A6/30/20174,074533N/A549N/A3/31/20173,265333N/A375N/A12/31/20162,574111N/A-21N/A9/30/20163,213103N/A-167N/A6/30/20163,748101N/A31N/A3/31/20164,060118N/A-46N/A12/31/20154,042138N/A-146N/A9/30/20153,54863N/A-188N/Aもっと見るアナリストによる今後の成長予測収入対貯蓄率: 000990の予測収益成長が 貯蓄率 ( 2.4% ) を上回っているかどうかを判断するにはデータが不十分です。収益対市場: 000990の収益がCN市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です高成長収益: 000990の収益が今後 3 年間で 大幅に 増加すると予想されるかどうかを判断するにはデータが不十分です。収益対市場: 000990の収益がCN市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。高い収益成長: 000990の収益が年間20%よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。一株当たり利益成長率予想将来の株主資本利益率将来のROE: 000990の 自己資本利益率 が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です成長企業の発掘7D1Y7D1Y7D1YMaterials 業界の高成長企業。View Past Performance企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/07/23 18:28終値2026/07/23 00:00収益2026/03/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社のGitHubページでご覧いただけます。また、レポートの活用方法に関するガイドやYouTubeのチュートリアルも用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Chengzhi Co., Ltd. 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。1 アナリスト機関Wei LiuHaitong International Research Limited
Board Change • Jul 08High number of new and inexperienced directorsThere are 9 new directors who have joined the board in the last 3 years. The company's board is composed of: 9 new directors. 2 experienced directors. No highly experienced directors. Non-Employee Supervisor Shan Liu is the most experienced director on the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.
お知らせ • Jun 30Chengzhi Co., Ltd. to Report First Half, 2026 Results on Aug 13, 2026Chengzhi Co., Ltd. announced that they will report first half, 2026 results on Aug 13, 2026
お知らせ • Jun 09Chengzhi Co., Ltd., Annual General Meeting, Jun 29, 2026Chengzhi Co., Ltd., Annual General Meeting, Jun 29, 2026, at 14:00 China Standard Time. Location: 17F, Tower B, Innovation Building, Tsinghua Science and Technology Park, Beijing China
お知らせ • Mar 31Chengzhi Co., Ltd. to Report Q1, 2026 Results on Apr 15, 2026Chengzhi Co., Ltd. announced that they will report Q1, 2026 results on Apr 15, 2026
お知らせ • Dec 31Chengzhi Co., Ltd. to Report Fiscal Year 2025 Results on Apr 15, 2026Chengzhi Co., Ltd. announced that they will report fiscal year 2025 results on Apr 15, 2026
お知らせ • Sep 30Chengzhi Co., Ltd. to Report Q3, 2025 Results on Oct 25, 2025Chengzhi Co., Ltd. announced that they will report Q3, 2025 results on Oct 25, 2025
お知らせ • Jul 02Chengzhi Co., Ltd. to Report First Half, 2025 Results on Aug 08, 2025Chengzhi Co., Ltd. announced that they will report first half, 2025 results on Aug 08, 2025
お知らせ • Apr 18Chengzhi Co., Ltd. Approves Cash Dividend for 2024Chengzhi Co., Ltd. announced at its annual general meeting of 2024 held on 16 April 2025, approved the cash dividend of CNY 0.50000000 per 10 shares (tax included).
お知らせ • Mar 31Chengzhi Co., Ltd. to Report Q1, 2025 Results on Apr 24, 2025Chengzhi Co., Ltd. announced that they will report Q1, 2025 results on Apr 24, 2025
お知らせ • Mar 28Chengzhi Co., Ltd. Proposes Final Cash Dividend for 2024Chengzhi Co., Ltd. announced on 27 March 2025 the profit distribution proposal for 2024 as follows: final cash dividend of CNY 0.50000000 per 10 shares (tax included).
お知らせ • Mar 27Chengzhi Co., Ltd., Annual General Meeting, Apr 16, 2025Chengzhi Co., Ltd., Annual General Meeting, Apr 16, 2025, at 14:00 China Standard Time. Location: 17F, Tower B, Innovation Building, Tsinghua Science and Technology Park, Beijing China
お知らせ • Dec 31Chengzhi Co., Ltd. to Report Fiscal Year 2024 Results on Mar 27, 2025Chengzhi Co., Ltd. announced that they will report fiscal year 2024 results on Mar 27, 2025
Reported Earnings • Oct 25Third quarter 2024 earnings released: EPS: CN¥0.026 (vs CN¥0.14 in 3Q 2023)Third quarter 2024 results: EPS: CN¥0.026 (down from CN¥0.14 in 3Q 2023). Revenue: CN¥2.58b (down 26% from 3Q 2023). Net income: CN¥31.3m (down 81% from 3Q 2023). Profit margin: 1.2% (down from 4.8% in 3Q 2023). Revenue is forecast to grow 20% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 47 percentage points per year, which is a significant difference in performance.
お知らせ • Sep 30Chengzhi Co., Ltd. to Report Q3, 2024 Results on Oct 25, 2024Chengzhi Co., Ltd. announced that they will report Q3, 2024 results on Oct 25, 2024
Valuation Update With 7 Day Price Move • Sep 27Investor sentiment improves as stock rises 18%After last week's 18% share price gain to CN¥7.53, the stock trades at a forward P/E ratio of 29x. Average forward P/E is 16x in the Chemicals industry in China. Total loss to shareholders of 53% over the past three years.
Reported Earnings • Jul 26Second quarter 2024 earnings released: EPS: CN¥0.027 (vs CN¥0.017 in 2Q 2023)Second quarter 2024 results: EPS: CN¥0.027 (up from CN¥0.017 in 2Q 2023). Revenue: CN¥2.94b (down 7.7% from 2Q 2023). Net income: CN¥33.1m (up 59% from 2Q 2023). Profit margin: 1.1% (up from 0.7% in 2Q 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 53 percentage points per year, which is a significant difference in performance.
お知らせ • Jun 29Chengzhi Co., Ltd. to Report First Half, 2024 Results on Jul 26, 2024Chengzhi Co., Ltd. announced that they will report first half, 2024 results on Jul 26, 2024
Declared Dividend • May 25Dividend reduced to CN¥0.05Dividend of CN¥0.05 is 55% lower than last year. Ex-date: 29th May 2024 Payment date: 29th May 2024 Dividend yield will be 0.6%, which is lower than the industry average of 2.6%.
お知らせ • May 25Chengzhi Co., Ltd. Announces Final Cash Dividend on A Shares for the Year 2023, Payable on 29 May 2024Chengzhi Co., Ltd. announced final cash dividend/10 shares (tax included) of CNY 0.50000000 on A shares for the year 2023. Record date: 28 May 2024. Ex-date: 29 May 2024. Payment date: 29 May 2024.
Valuation Update With 7 Day Price Move • May 10Investor sentiment improves as stock rises 16%After last week's 16% share price gain to CN¥8.95, the stock trades at a trailing P/E ratio of 28x. Average trailing P/E is 35x in the Chemicals industry in China. Total loss to shareholders of 35% over the past three years.
Reported Earnings • Apr 17First quarter 2024 earnings released: EPS: CN¥0.13 (vs CN¥0.047 loss in 1Q 2023)First quarter 2024 results: EPS: CN¥0.13 (up from CN¥0.047 loss in 1Q 2023). Revenue: CN¥2.72b (down 19% from 1Q 2023). Net income: CN¥154.1m (up CN¥211.0m from 1Q 2023). Profit margin: 5.7% (up from net loss in 1Q 2023). Revenue is forecast to grow 17% p.a. on average during the next 2 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 60 percentage points per year, which is a significant difference in performance.
お知らせ • Apr 05Chengzhi Co., Ltd. Approves Cash Dividend for 2023Chengzhi Co., Ltd. at its Annual General Meeting of 2023 held on 02 April 2024, the shareholders approved: cash dividend/10 shares (tax included): CNY 0.50000000 for the year 2023.
お知らせ • Mar 30Chengzhi Co., Ltd. to Report Q1, 2024 Results on Apr 17, 2024Chengzhi Co., Ltd. announced that they will report Q1, 2024 results on Apr 17, 2024
お知らせ • Mar 14Chengzhi Co., Ltd., Annual General Meeting, Apr 02, 2024Chengzhi Co., Ltd., Annual General Meeting, Apr 02, 2024, at 14:00 China Standard Time. Location: 17F, Tower B, Innovation Building, TusPark, Beijing China Agenda: To consider 2023 work report of the board of directors; to 2023 work report of the supervisory committee; to 2023 annual report and its summary; to 2023 annual accounts report; to 2023 profit distribution plan; to 2023 assets write-off and provision for assets impairment; to 2024 application for comprehensive credit line to banks; to 2024 provision of guarantee for controlled subsidiaries; and to consider other matters.
Reported Earnings • Mar 13Full year 2023 earnings released: EPS: CN¥0.15 (vs CN¥0.044 in FY 2022)Full year 2023 results: EPS: CN¥0.15 (up from CN¥0.044 in FY 2022). Revenue: CN¥12.4b (up 6.0% from FY 2022). Net income: CN¥177.4m (up 236% from FY 2022). Profit margin: 1.4% (up from 0.5% in FY 2022). Revenue is forecast to grow 13% p.a. on average during the next 2 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 55 percentage points per year, which is a significant difference in performance.
Valuation Update With 7 Day Price Move • Feb 02Investor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to CN¥6.72, the stock trades at a forward P/E ratio of 17x. Average forward P/E is 13x in the Chemicals industry in China. Total loss to shareholders of 38% over the past three years.
お知らせ • Dec 30Chengzhi Co., Ltd. to Report Fiscal Year 2023 Results on Feb 29, 2024Chengzhi Co., Ltd. announced that they will report fiscal year 2023 results on Feb 29, 2024
New Risk • Dec 22New major risk - Revenue and earnings growthEarnings have declined by 22% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 22% per year over the past 5 years. Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Large one-off items impacting financial results.
お知らせ • Dec 13+ 1 more updateChengzhi Co., Ltd.(SZSE:000990) dropped from Shenzhen Stock Exchange Component IndexChengzhi Shareholding Co., Ltd. has been removed from Shenzhen Stock Exchange Component Index .
Reported Earnings • Oct 27Third quarter 2023 earnings released: EPS: CN¥0.14 (vs CN¥0.098 loss in 3Q 2022)Third quarter 2023 results: EPS: CN¥0.14 (up from CN¥0.098 loss in 3Q 2022). Revenue: CN¥3.47b (up 22% from 3Q 2022). Net income: CN¥166.9m (up CN¥285.3m from 3Q 2022). Profit margin: 4.8% (up from net loss in 3Q 2022). Revenue is forecast to grow 12% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 57% per year but the company’s share price has only fallen by 16% per year, which means it has not declined as severely as earnings.
お知らせ • Sep 30Chengzhi Co., Ltd. to Report Q3, 2023 Results on Oct 27, 2023Chengzhi Co., Ltd. announced that they will report Q3, 2023 results on Oct 27, 2023
お知らせ • Jul 01Chengzhi Co., Ltd. to Report First Half, 2023 Results on Aug 12, 2023Chengzhi Co., Ltd. announced that they will report first half, 2023 results on Aug 12, 2023
お知らせ • Jun 06Chengzhi Co., Ltd. Announces 2022 Final Profit Distribution Plan to Be Implemented (A Shares), Payable on 09 June 2023Chengzhi Co., Ltd. announced 2022 final profit distribution plan to be implemented (A shares) of Cash dividend/10 shares (tax included): CNY 1.10000000. Record date: 08 June 2023; Ex-date: 09 June 2023; Payment date: 09 June 2023.
Reported Earnings • Mar 26Full year 2022 earnings released: EPS: CN¥0.044 (vs CN¥0.83 in FY 2021)Full year 2022 results: EPS: CN¥0.044 (down from CN¥0.83 in FY 2021). Revenue: CN¥11.7b (down 3.8% from FY 2021). Net income: CN¥52.9m (down 95% from FY 2021). Profit margin: 0.5% (down from 8.3% in FY 2021). Over the last 3 years on average, earnings per share has increased by 6% per year but the company’s share price has fallen by 12% per year, which means it is significantly lagging earnings.
Board Change • Nov 16High number of new and inexperienced directorsThere are 8 new directors who have joined the board in the last 3 years. The company's board is composed of: 8 new directors. 2 experienced directors. No highly experienced directors. Independent Director Yaxiong Guo is the most experienced director on the board, commencing their role in 2017. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.
Reported Earnings • Oct 29Third quarter 2022 earnings released: CN¥0.098 loss per share (vs CN¥0.30 profit in 3Q 2021)Third quarter 2022 results: CN¥0.098 loss per share (down from CN¥0.30 profit in 3Q 2021). Revenue: CN¥2.84b (down 11% from 3Q 2021). Net loss: CN¥118.5m (down 132% from profit in 3Q 2021). Over the last 3 years on average, earnings per share has increased by 18% per year but the company’s share price has fallen by 14% per year, which means it is significantly lagging earnings.
Board Change • Oct 09High number of new and inexperienced directorsThere are 7 new directors who have joined the board in the last 3 years. The company's board is composed of: 7 new directors. 5 experienced directors. No highly experienced directors. Independent Director Yaxiong Guo is the most experienced director on the board, commencing their role in 2017. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.
Reported Earnings • Jul 25First half 2022 earnings released: EPS: CN¥0.12 (vs CN¥0.61 in 1H 2021)First half 2022 results: EPS: CN¥0.12 (down from CN¥0.61 in 1H 2021). Revenue: CN¥6.48b (up 1.3% from 1H 2021). Net income: CN¥149.9m (down 80% from 1H 2021). Profit margin: 2.3% (down from 12% in 1H 2021). Over the last 3 years on average, earnings per share has increased by 30% per year but the company’s share price has fallen by 12% per year, which means it is significantly lagging earnings.
Buying Opportunity • Jul 23Now 21% undervalued after recent price dropOver the last 90 days, the stock is down 4.9%. The fair value is estimated to be CN¥12.87, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 29% over the last 3 years. Earnings per share has grown by 31%.
Buying Opportunity • Jul 06Now 20% undervalued after recent price dropOver the last 90 days, the stock is down 14%. The fair value is estimated to be CN¥13.39, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 29% over the last 3 years. Earnings per share has grown by 31%. Revenue is forecast to grow by 29% in 2 years. Earnings is forecast to decline by 12% in the next 2 years.
Buying Opportunity • Jun 10Now 20% undervalued after recent price dropOver the last 90 days, the stock is down 16%. The fair value is estimated to be CN¥13.05, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 29% over the last 3 years. Earnings per share has grown by 31%. Revenue is forecast to grow by 29% in 2 years. Earnings is forecast to decline by 12% in the next 2 years.
Reported Earnings • Apr 27First quarter 2022 earnings released: EPS: CN¥0.12 (vs CN¥0.27 in 1Q 2021)First quarter 2022 results: EPS: CN¥0.12 (down from CN¥0.27 in 1Q 2021). Revenue: CN¥3.36b (up 12% from 1Q 2021). Net income: CN¥146.4m (down 55% from 1Q 2021). Profit margin: 4.4% (down from 11% in 1Q 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 31% per year but the company’s share price has fallen by 26% per year, which means it is significantly lagging earnings.
Reported Earnings • Oct 20Third quarter 2021 earnings released: EPS CN¥0.30 (vs CN¥0.20 in 3Q 2020)The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: CN¥3.17b (up 17% from 3Q 2020). Net income: CN¥365.7m (up 49% from 3Q 2020). Profit margin: 12% (up from 9.1% in 3Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 14% per year but the company’s share price has only increased by 7% per year, which means it is significantly lagging earnings growth.
Valuation Update With 7 Day Price Move • Aug 04Investor sentiment improved over the past weekAfter last week's 24% share price gain to CN¥17.47, the stock trades at a forward P/E ratio of 14x. Average forward P/E is 19x in the Chemicals industry in China. Total returns to shareholders of 29% over the past three years.
Reported Earnings • Jul 27Second quarter 2021 earnings released: EPS CN¥0.34 (vs CN¥0.042 loss in 2Q 2020)The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: CN¥3.41b (up 73% from 2Q 2020). Net income: CN¥416.4m (up CN¥467.2m from 2Q 2020). Profit margin: 12% (up from net loss in 2Q 2020). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 6% per year but the company’s share price has increased by 2% per year, which means it is well ahead of earnings.
Reported Earnings • Apr 16First quarter 2021 earnings released: EPS CN¥0.27 (vs CN¥0.13 loss in 1Q 2020)The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: CN¥2.99b (up 49% from 1Q 2020). Net income: CN¥322.3m (up CN¥477.8m from 1Q 2020). Profit margin: 11% (up from net loss in 1Q 2020). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 30% per year but the company’s share price has only fallen by 4% per year, which means it has not declined as severely as earnings.
Analyst Estimate Surprise Post Earnings • Mar 05Revenue beats expectationsRevenue exceeded analyst estimates by 25%. Over the next year, revenue is expected to shrink by 14% compared to a 51% growth forecast for the Chemicals industry in China.
Reported Earnings • Mar 05Full year 2020 earnings released: EPS CN¥0.29 (vs CN¥0.36 in FY 2019)The company reported a mediocre full year result with weaker earnings and profit margins, although revenues improved. Full year 2020 results: Revenue: CN¥9.73b (up 41% from FY 2019). Net income: CN¥355.1m (down 20% from FY 2019). Profit margin: 3.6% (down from 6.4% in FY 2019). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 44% per year but the company’s share price has only fallen by 5% per year, which means it has not declined as severely as earnings.
Is New 90 Day High Low • Mar 05New 90-day high: CN¥14.38The company is up 1.0% from its price of CN¥14.27 on 04 December 2020. The Chinese market is also up 1.0% over the last 90 days, indicating the company’s price trend is similar to the market over that time. However, it underperformed the Chemicals industry, which is up 11% over the same period.
Is New 90 Day High Low • Jan 27New 90-day low: CN¥11.00The company is down 15% from its price of CN¥12.95 on 30 October 2020. The Chinese market is up 9.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 21% over the same period.
Is New 90 Day High Low • Jan 11New 90-day low: CN¥11.21The company is down 15% from its price of CN¥13.24 on 14 October 2020. The Chinese market is up 5.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 12% over the same period.
Is New 90 Day High Low • Dec 25New 90-day low: CN¥12.78The company is down 1.0% from its price of CN¥12.94 on 25 September 2020. The Chinese market is up 5.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 10.0% over the same period.